Archives

by in
Entry Author Date Location
Adimab Grows Up, Looks to Pay Off the VCs In Unusual Way 02/22/13 Boston
Join Us at “Biotech in the Belt-Tightening Era” April 9 in Seattle 02/14/13 Seattle
Seattle Genetics Gets $138M in First-Year Sales of Cancer Drug 02/12/13 Seattle
Companion Diagnostics for Cancer Drugs Advancing Personalized Medicine 01/31/13 Boston
Who Are Biotech’s New Go-To Investment Bankers? 11/12/12 National
Seattle Genetics, Millennium Cancer Drug Cleared in EU 10/31/12 Seattle
Seattle Genetics Gets $25M in Broader Abbott Deal 10/23/12 Seattle
Exclusive: OVP Venture Partners, NW’s Oldest VC Firm, To Shut Down 10/11/12 Seattle
Betting on Biotech to Catalyze U.S. Job Growth? Don’t Count On It 10/01/12 National
Seattle Genetics Gets $34.7M in Second-Quarter Sales of Cancer Drug 08/08/12 Seattle
U.S. Biotech Clusters Are Losing Their Anchor Tenants, and It Hurts 08/06/12 National
Actinium Advances Armed Cancer Drugs, Preps for Wall Street Debut 08/01/12 New York
Seattle Genetics, Millennium Get EU Recommendation for Lymphoma Drug 07/20/12 Seattle
Life Science Innovation NW Notes: SeaGen, NanoString, Viket, & More 07/12/12 Seattle
Gates Foundation’s Jeff Raikes To Start Off Seattle Biotech Event 07/10/12 Seattle
The Best Boring Companies in Biotech 07/09/12 National
Merck Bets $15M on Ambrx’s “Smart Bomb” Antibodies 06/18/12 San Diego
ASCO Wrap-Up: A Summary of This Week’s Cancer R&D Headlines 06/05/12 National
NanoString Nabs Ex-Seattle Genetics Exec to Lead Diagnostic Push 05/29/12 Seattle
Seattle Genetics Follows the Science, Taking on Rare Lymphoma No. 3 05/23/12 Seattle
Who’s on Biotech’s Endangered Species List? Mid-Sized Drugmakers 05/21/12 National
Targeted Cancer Drugs With Punch: The Next Big Class of Antibodies 05/16/12 National
Seattle Genetics Misses 1st Quarter Sales Estimate, But Sees $1B Future 05/08/12 Seattle
Sutro Biopharma Pulls in $16M for New Antibody Drugs 05/08/12 San Francisco
Mersana Adds $4M For Next-Generation “Armed” Cancer Drugs 05/01/12 Boston
Abbott’s Humira, the 3rd-in-Class Drug That Toppled Lipitor as No. 1 04/16/12 National
Seattle Genetics Digs Deeper Into the Proverbial Haystack 03/13/12 National
Reinventing Biotech on April 3: Here’s the Agenda 03/08/12 Seattle
Seattle Genetics Gets New Commercial Boss for Early Days of Adcetris 02/23/12 Seattle
Seattle Genetics Sees Updated Side Effect Warning in Drug Label 01/13/12 Seattle
Page 2 of 9 « previous page · next page »